Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have earned an average recommendation of “Hold” from the six research firms that are covering the stock, MarketBeat reports.

Headquartered in Mountain View, CA, Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply ...

But really big losses can really drag down an overall portfolio. So spare a thought for the long term shareholders of Omnicell, Inc. (NASDAQ:OMCL); the share price is down a whopping 75% in the ...

Omnicell’s OMCL strength in its SaaS and Expert Services offerings should help sustain growth in the upcoming quarters. Efforts to expand into overseas markets instill optimism. However, adverse ...